Physician profile
Andrew E Yang
NPI 1700205986
$12,532.35
in general payments reported to CMS, 2019-2025
12 companies · $407 in 2025
The $407 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $229 · 2020: $318 · 2021: $486 · 2022: $336 · 2023: $571 · 2024: $10K · 2025: $407.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $10K · Food and Beverage: $1,122.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $10,041.67 |
| Food and Beverage | $1,122.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $10,086.61 | 2024-2025 | Auryon Laser System 100-120 Vac, Auryon Laser System 100-120 Vac |
| Endologix LLC | $897.87 | 2021-2024 | Alto Abdominal Stent Graft System, Endocross Device, Torus Stent Graft System |
| Medtronic Vascular, INC. | $476.00 | 2019-2020 | |
| W. L. Gore & Associates, INC. | $358.81 | 2022-2023 | Gore Tag Thoracic Branch Endoprosthesis |
| Penumbra, INC. | $338.28 | 2025 | Indigo System |
| Inari Medical, INC. | $144.17 | 2021 | |
| Medtronic, INC. | $113.76 | 2022 | |
| Davol INC. | $30.00 | 2019 | |
| Allergan, INC. | $24.04 | 2019 | |
| Boston Scientific Corporation | $23.39 | 2025 | Angiojet Ultra 5000a |
| Bioventus LLC | $22.73 | 2021 | |
| Csl Behring | $16.69 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Yang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.